we have been able to successfully trap both the subthe MIR electron density maps. On the basis of these maps, we could readily build the entire 202 amino acid strate and reaction product within the protein, allowing us to outline the interactions between VanX and both its polypeptide chain into the density representing one VanX molecule. The molecular transforms from this molsubstrate and product. Finally, we have also determined the structure of VanX in complex with two transitionecule to other molecules in the ASU were then applied to reconstruct the entire ASU. Each amino acid residue state analogs to outline interactions between the protein and initial therapeutic compounds. The implications of within the other five VanX molecules was then positioned into density. The protein structure was refined using the the known structure to related VanX sequence orthologs will be discussed, and the structure will be compared programs X-PLOR (Brü nger, 1990 ) and CNS (Brü nger et al., 1998) until convergence of the refinement was to two known structural homologs, N-acyl-D-ala-D-ala carboxypeptidase of Streptomyces albus G (Dideberg reached . Following this, a 2.2 Å native data set was collected at a synchrotron source, and the native strucet al., 1982) and the N-terminal fragment of murine Sonic hedgehog protein (Hall et al., 1995) .
ture was further refined against these data. The structures of VanX:ligand complexes were determined by soaking the VanX crystals within 0.5-1.0 ml Results and Discussion of stabilizing solution, each containing 5-160 mM of the ligand for varying periods. The crystals were then flashStructure Determination and Overview The VanX protein was purified and crystallized as defrozen and data collected. It should be noted that inhibitors are not bound in completely identical modes within scribed (Experimental Procedures). There is a hexamer in the crystallographic asymmetric unit (ASU). The best each VanX active site in the ASU in most cases. This is due to small conformational differences between the six VanX crystals diffracted to 2.1 Å on in-house systems and to 1.7 Å at synchrotron sources (the X12C beamlineVanX molecules within the ASU. The current ratio of degrees of freedom within the ASU versus the number Brookhaven National Laboratory and the IMCA beamline-Advanced Photon Source). There is considerable of reflections at 2.2 Å requires the use of a noncrystallographic symmetry (NCS) restraint within the refinement unit cell heterogeneity among individual VanX crystals; this is most certainly due to the organization of the protocol to prevent overfitting. This NCS restraint prevents us from identifying these differences. Accurate crystallographic asymmetric unit (ASU). The six molecules of VanX form an extended column or "filament" identification of the differences between each monomer in the ASU will require the refinement of VanX to a much approximately parallel to the crystal c axis. Small rotations of this filament lead to unit cell changes of approxihigher resolution. Representative electron density for the native protein structure is shown in Figure 2 . mately 1%-5% within the unit cell parameters.
The structure of VanX was determined by multiple isomorphous replacement (MIR), using a 2.8 Å native
Overall Structure VanX is a globular protein, formally a member of the data set and three heavy atom derivatives (Table 1) . Density modification was combined with noncrystallo-␣ϩ␤ class. The core of the protein is formed by a fivestranded ␤ sheet of mixed polarity and a pronounced graphic symmetry averaging to improve the quality of curvature (␤2, ␤4, ␤5, ␤6, and ␤7). This core is bordered by several long ␣ helices (␣1, ␣2, ␣3, and ␣5) and a few short 3 10 helices (H1, H2, and H3) (Figure 3 ). The fivestranded ␤ sheet is formed by two smaller antiparallel ␤ sheets, with the first comprised of ␤6 and ␤7, and the second comprised of ␤2, ␤4, and ␤5. A smaller antiparallel ␤ sheet, which borders the edge of the protein, is formed by strands ␤1 and ␤3. While there is extensive hydrogen bonding between the individual strands of the largest ␤ sheet, the roll of the sheet makes it more sporadic than is normal. The elements of secondary structure within the protein are connected by long regions of coil. An electrostatic profile analysis of the protein reveals that it has a high, uniform, negative electrostatic potential distributed across the entire surface of the molecule ( Figure 4D ). One unusual feature of the protein structure is the protrusion of a single tryptophan side chain (Trp-24) into solution where it interacts with a symmetry-related Trp-24Ј from an adjacent molecule. The area around this tryptophan may represent a dimerization surface for the VanX molecule, which exists in solution in both a monomeric and dimeric form (Wu et al., 1995) ; this dimerization has no known in vivo function.
The VanX Active Site and Implications for the Enzymatic Mechanism
The active site of VanX is compact, being held entirely within a cavity of approximately 150 Å 3 . This small cavity ( Figure 4D ) is only capable of accommodating a dipeptide within its perimeter. The size of the cavity is quite small compared to the active site pockets of other zinc peptidases. This is the origin of the very narrow sub- Key portions of secondary structure are labeled, and the N and C termini are also identified. ␤ strands are shown in red, turns/coil in orange, 310 helices in light blue, and ␣ helices in green. The zinc ion is shown as a yellow sphere. The illustration was prepared using RIBBONS (Carson, 1987). against only a few dipeptides (D-alanyl-D-alanine, D-alasteps involve proton donation from either the acidic group or another water molecule to the scissile nitrogen, nyl-D-phenylalanine, D-alanyl-glycine, DL-alanyl-DLfollowed by cleavage of the peptide ( Figure 1A ). In VanX, serine, DL-alanyl-DL-valine, DL-alanyl-DL-asparagine), this catalytic water is found hydrogen-bonded to Gluand has shown no activity against tripeptides or L-,L-181 at a distance of 2.9 Å and is within 3.1 Å of the dipeptides (Wu et al., 1995) . This establishes it as a zinc ion ( Figure 4A ). Glu-181 has been revealed as the dipeptidase. The active site cavity is amphipathic and catalytic base by mutational analysis (McCafferty et al., approximately rectangular in shape: three of the "sides" 1997). Arg-71 is also found within hydrogen-bonding are hydrophilic and one is hydrophobic. Most members distance of the catalytic water (3.37 Å ), which may conof the cavity are presented by elements of secondary tribute to the increased polarization of this water. The structure: Asp-68 (␤4), , arrangement of the groups is identical to that proposed Ser-115 (H3), His-116 (H3), Ala-121 (␤5), , by Walsh and coworkers on the basis of biochemical Asp-123 (␤5), , and mutational data (McCafferty et al., 1997) . and His-184 (␤7) form the perimeter of the cavity. The opening of the cavity is ringed with residues capable of both accepting and donating hydrogen bonds (mainly Binding of D-ala-D-ala and D-ala serines), giving this entry ring a highly polar character.
It has been observed that CuCl2 is capable of inhibiting The entire cavity shows a high negative electrostatic the enzymatic activity of VanX (Wu et al., 1995) . This potential ( Figure 4D) , 1996) . By using CuCl 2 in conjunction with a competigroup is a structural water. These critical side chains were tive soak of D-ala-D-ala and D-ala, it was possible to previously identified by mutational analysis (McCafferty trap both the dipeptide substrate and amino acid prodet al., 1997). The coordinating groups form a quasitetrauct within individual active sites. The binding affinity of hedral geometry with respect to the Zn 2ϩ ion.
VanX for the D-ala-D-ala substrate is nominal (with a K m Previous work has outlined the steps necessary for of approximately 1 mM) (Wu et al., 1995) , so a high catalysis by a Zn 2ϩ peptidase (Mock and Askamawati, concentration of substrate was necessary (see Experi-1994; McCafferty et al., 1997 ) ( Figure 1A ). It has been mental Procedures). Inspection of the electron density proposed that the initial peptide cleavage step involves maps clearly revealed that D-ala bound in five molecules the displacement of a zinc-bound water molecule by an of the asymmetric unit, while in one molecule the comincoming peptide. This water molecule, activated by the plete D-ala-D-ala dipeptide could be seen. Examination influence of the zinc ion and possibly by the influence of of the dipeptide revealed that it bound as hypothesized a nearby acidic group such as a glutamate or aspartate and that the mode of binding was consistent with the residue (the "catalytic base"), attacks the peptide car- Key protein-substrate/product or -inhibitor interactions are shown. The catalytic zinc is shown as a yellow sphere. Distances between interacting groups are described within the figure text. In the case of (B) and (C), the structures of the substrate/product complexes and the analog complexes have been superimposed for the purpose of comparison. (A) The active site of VanX. The catalytic zinc coordinates to His-116, Asp-123, His-184, and the structural water (shown as a red sphere) at a distance of 2.45 Å , 3.01 Å , 2.50 Å , and 3.14 Å , respectively. Glu-181, which is postulated to aid in activation of the catalytic base, is shown, as is Arg-71, which stabilizes the transition state. The ␤ strands are shown as arrows.
(B) The binding of D-ala-D-ala (substrate) and D-ala (product) within the active site. The D-ala-D-ala dipeptide is shown with its carbon atoms colored white. Its amino terminus labeled with a red "N" and the carboxyl terminus labeled "O." The D-ala amino acid's carbon atoms are colored magenta. The yellow arrow indicates the entrance of the active site cavity. Ligand-side chain interactions are identified by dashed lines (white for the dipeptide, magenta for the amino acid). The amino group donates hydrogen bonds to Tyr-21, Asp-123, and Asp-142, with distances of 3.16 Å , 3.51 Å , and 2.90 Å ; the carbonyl coordinates directly to the catalytic zinc at a distance of 2.48 Å . The bridging amide (within the green circle) donates a hydrogen to the backbone carbonyl of Tyr-109; the carboxylate accepts hydrogen bonds from Ser-115 at a distance of 3.16 Å . The D-ala amino acid shows a more narrow range of interaction. The amino group donates hydrogen bonds to Tyr-21, Asp-123, and Asp-142, with distances of 3.84 Å , 3.23 Å , and 3.32 Å . One oxygen of the carboxylate coordinates to the catalytic zinc at a distance of 2.86 Å ; the other oxygen coordinates to the backbone amide of Ala-111, which is brought into position by a rearrangement of residues 108-113 (shown by the magenta arrow) in those molecules that bound D-ala. (C) The binding of the phosphinate and phosphonate transition-state analogs within the active site. The amino terminus of the analogs is labeled with a red "N," the phosphorous portion with a red "P," and the carboxyl terminus with a red "O." The phosphonate analog is shown with white carbons and the phosphinate analog is shown with magenta carbons. Analog-side chain interactions are shown in dashed lines (white for the phosphonate and magenta for the phosphinate). In the phosphinate, the amino group donates hydrogen bonds to Tyr-21, Asp-123, and Asp-142, with distances of 2.96 Å , 3.03 Å , and 2.82 Å ; both oxygens of the phosphinate moiety coordinate directly to the catalytic zinc at a distance of approximately 2.5 Å ; the carboxylate accepts hydrogen bonds from Ser-114 at a distance of 2.78 Å . In the phosphonate complex, the interactions are equivalent, except for the amino group that is rotated 180Њ about the carbon-phosphorous bond. The amino group donates hydrogen bonds to Asp-142 and Glu-181 with distances of 3.59 Å and 3.88 Å ; both oxygens of the phosphinate moiety coordinate directly to the catalytic zinc at a distance of approximately 2.5 Å ; the carboxylate accepts hydrogen bonds from Ser-114 at a distance of 2.64 Å . (D) Surface electrostatic potential of the VanX protein. The electrostatic potential is superimposed on the solvent-accessible surface of VanX calculated using a water probe radius of 1.4 Å . The calculations were performed using GRASP (Nicholls et al., 1991) . The ranges of red (negative) and blue (positive) represent electrostatic potentials of ϽϪ15 to Ͼϩ15 k bT, where kb is the Boltzmann constant and T is the temperature. White represents nonpolar residues. In the calculations, the pH is 7.0, and the dielectric constants for the solvent and protein are 80 and 2, respectively. The active site cavity is identified by a green box, and the phosphinate analog is shown within the cavity.
carboxylate of residue 2 protruding out of the pocket.
group of each alanine is found making favorable Van der Waals contacts: the methyl group of residue 1 interThis binding mode establishes VanX as an amino-peptidase, a result that was confirmed by the structure of acts with Phe-27, Phe-29, and ⑀-carbon of Met-144, while the methyl group of residue 2 interacts with Serthe protein complexed with transition-state analogs. The protein-substrate interactions are divided into N-termi-114. Finally, the carboxylate is found to form hydrogen bonds with Ser-115. Inspection of the active site reveals nal and C-terminal portions, corresponding to each amino acid comprising the dipeptide. The amino group that the selectivity of the enzyme is derived mainly from steric constraints. Given that the positions of the amino makes key hydrogen bonds with Tyr-21, Asp-123, and Asp-142. These side chains are crucial, as they are posigroup and the dipeptide carbonyl are held fixed through interaction with the protein and the zinc, at the residue tioned to allow maximum hydrogen-bonding efficiency with the amino terminus of the dipeptide. Shared elec-1 position, an L-amino acid would necessarily protrude into a hydrophilic area formed by Asp-142, Glu-181, and tron density is seen between each of these side chains and the amino group, indicating strong hydrogen bondTrp-183 where it would make inappropriate contacts. This would prevent an L-isomer at the residue 1 position. ing. The amide nitrogen hydrogen-bonds to the backbone carbonyl of Tyr-109. Arg-71 is positioned above
The overall shape of the pocket would also prevent a dipeptide with a long D-amino acid at the first residue the Zn 2ϩ and the dipeptide carbonyl, ideally placed to stabilize the tetrahedral transition state. The methyl from binding. The active site is far less restrictive at the carboxyl terminus of the dipeptide, where slightly larger phosphonate analog (Wu and Walsh, 1995; Wu et al., 1995) ? The structure of the VanX:phosphonate complex D-isomers can be accommodated (the shape of the reveals that the compound binds much as predicted pocket still favors a D-isomer, however). This categori- (Wu and Walsh, 1995; Wu et al., 1995) ( Figure 4C ). Unlike zation of specificity has been confirmed by enzymatic the VanX:D-ala-D-ala complex, the shared density that studies that show that only D-alanine and D-serine are represents the triad of hydrogen bonds between the allowed at the residue 1 position, while the residue 2 protein and the amino group of residue 1 is not seen. position has considerably more variability.
Therefore, we have positioned the amino group in the Examination of the D-ala amino acid bound in the opposite position (via a 180Њ rotation about the carbonother five molecules of the ASU provides a view as to phosphorous bond), where it hydrogen-bonds to Asphow the enzyme binds product ( Figure 4B ). The D-ala 142 and Glu-181. Both phosphonate oxygens coordioccupies a position equivalent to the amino half of the nate to the zinc at a distance of 2.5 Å . One of the oxygens dipeptide, with its carboxylate coordinating to the zinc, also forms a salt link with Arg-71, illustrating this resias well as accepting a hydrogen bond from His-116. It due's key role in stabilizing the tetrahedral transition is also positioned to accept a hydrogen bond from Argstate. The compound's carboxylate moiety is positioned 71. As with D-ala-D-ala, the amino nitrogen donates to be a hydrogen-bond acceptor for both Arg-71 and three hydrogen bonds to Tyr-21, Asp-123, and Asp-142.
Ser-114. Unlike D-ala-D-ala, the methyl groups of the Again, shared electron density is seen between these phosphonate analog do not make significant Van der three side chains and the amino group, indicating the Waals contacts with the active site cavity. strength of these particular hydrogen bonds. Unlike the The phosphinate analog binds to VanX in a manner molecule that bound D-ala-D-ala, the molecules that more similar to D-ala-D-ala ( Figure 4C ). The amino group bound D-ala show a rearrangement of the main chain of residue 1 is seen forming strong hydrogen bonds with between residues Val-110 and Ala-111. This rearrangeTyr-21, Asp-123, and Asp-142. As in the case of the ment involves the main-chain carbonyl of Val-110 swing-D-ala-D-ala complex, shared electron density is seen ing approximately 190Њ away from its D-ala-D-ala posibetween each of the side-chain acceptors and the amino tion, around the axis of the protein backbone. This brings group. Each of the phosphinate oxygens coordinates to the main-chain amide of Ala-111 into position to hydrothe zinc ion with a distance of 2.9 and 2.6 Å , respectively, gen-bond with the carboxylate of the amino acid suband one of the oxygens forms a favorable electrostatic strate.
interaction with Arg-71. Again, the carboxylate of resi-A structural rearrangement occurs in the active site of due 2 hydrogen-bonds with Arg-71 and Ser-114. As in VanX upon ligand binding. This rearrangement involves the phosphonate complex, the phosphinate methyl both individual side chains as well as portions of secgroups do not form significant Van der Waals contacts ondary structure. Residues 98-113 (␣4 and adjacent reswith the protein. The positioning of the phosphinate idues) shift 2.2 Å toward the active site. Residues 180-compound is virtually identical to that of D-ala-D-ala 186 (which include ␤7 and the residues immediately from the amino group to the tetrahedral phosphinate adjacent to them) move 0.75 Å toward the active site.
group. After this, the molecule deviates from the posiIn both of these cases, the relative orientations of the tioning of D-ala-D-ala by approximately 0.25 Å . With the side chains do not change. Met-104 moves 1.3 Å toward exception of the hydrophobic interactions formed by the edge of the active site and Met-144 migrates 2.8 Å the methyl groups, both transition-state analogs form into a pocket formed by Tyr-109 and Asp-142/Phe-143. more interactions with the protein than does the subIdentical rearrangements are seen in the VanX:transistrate, thereby explaining their superior K m s. While these tion-state analog complexes that are described in the transition-state analogs will provide a good template for section that follows. subsequent structure-based drug discovery, they suffer from poor bioavailability, making subsequent modification necessary for an adequate lead compound.
Binding of Phosphonate and Phosphinate
A factor that will prove challenging in using VanX as Transition-State Analogs a drug target will be the limited size of its active site. Based upon previous drug design efforts on Zn 2ϩ -The active site offers few "pockets" or specific regions dependent aminopeptidases, Wu and Walsh were able of interaction to exploit by rational drug design. Aside to characterize potent phosphonate (formally D-3-[(1-from those residues already mentioned, only two obviAminoethyl)phosphonyl]2-methylpropionic acid) and phosous pockets exist. The first, a small hydrophobic pocket phinate (D-3-[(1-Aminoethyl)phosphinyl]2-methylpropiimmediately adjacent to the first residue methyl group onic acid) inhibitors ( Figures 1B and 1C ) that mimick in the phosphinate compound, is formed by residues the tetrahedral adduct geometry of bound D-ala-D-ala Phe-27, Met-104, and Met-144. The second pocket, a reaction intermediates (Wu and Walsh, 1995; Wu et al., clustering of aromatic residues formed by Tyr-21, Phe-1995). These inhibitors bind with K is of 0.3 mM and 27, Phe-79, Phe-141, and Trp-183, is proximal to the 0.32 M for the phosphonate and phosphinate analogs, amino group of the first residue. Both offer the possibility respectively (Wu and Walsh, 1995; Wu et al., 1995) .
of increasing favorable interactions between inhibitors Structural studies of each of these two compounds and the protein by presenting hydrophobic moieties into bound to VanX were undertaken to answer two questhese pockets. Additional probing of the site via iterative tions. First, what interactions make these compounds drug design and examination of the subsequent VanX:insuccessful inhibitors? Second, why, despite minor difhibitor complex structures will be necessary to further ferences in molecular structure, is the phosphinate anaprobe the active site and identify sites of possible interaction. log three orders of magnitude more potent than the Examination of the differences between the binding of the homologies, divided between those isolated from gram-positive and gram-negative bacteria. The orthoaffinities and binding modes of the phosphonate and phosphinate analogs allows one to predict the origin of logs from E. faecilis and S. toyocaensis are most similar to the VanX presented herein, with an approximate 43% VanX selectivity for D-ala-D-ala versus D-ala-D-lac (Wu et al., 1995) . The determinants of the differences in bindidentity between all three proteins (the gram-positive cluster). The orthologs from E. coli and Synechocystis ing affinity between the two analogs are quite subtle. In fact, the structures can be superimposed with an rms sp. are more distant, showing far less identity, as well as large insertions and deletions (the gram-negative deviation of 0.18 Å (0.1 Å for the analogs alone). However, the difference in positioning of the residue 1 amino cluster). The gram-positive cluster has been shown to be involved in mediating vancomycin resistance (Wu et group in the phosphonate compound leads to a loss of one hydrogen bond between the protein and the transial., 1995; Marshall et al., 1998) . The cellular roles and enzymatic activities of the tion-state analog ( Figure 4C ). This is possibly compensated by internal hydrogen bonding between the bridggram-negative cluster have yet to be analyzed. Each ortholog in the gram-positive cluster shows a proing phosphonate oxygen and the amino group of the phosphonate analog, an arrangement that is not possinounced conservation of residues, especially in the active site ( Figure 5 ). Of special mention is the EWWH ble in the phosphinate analog. Second, quantum mechanical calculations have shown that the phosphonate motif beginning at Glu-181 in E. faecium, which is comprised of members of the VanX active site. This motif is bridging oxygen has a ␦-negative charge of approximately 0.27 with respect to the phosphinate carbon conserved in all identified VanX orthologs and provides an excellent fingerprint with which to identify further (Frisch et al., 1995) . This negatively charged phosphonate oxygen is positioned proximal to both the negaorthologs from genomics data. The high level of sequence identity among members of the gram-positive tively charged Glu-181 side chain (3.06 Å ) and a mainchain carbonyl group of Tyr-109 (3.4 Å ). The loss of cluster will be crucial in drug design projects, as a drug developed against one member will most likely be effecprotein:compound hydrogen bonding, as well as electrostatic repulsion between the compound and the protive against other members of this cluster. In addition to the primary sequence analysis, a search tein, would lead to the drastically reduced binding affinity. This most likely holds true for D-ala-D-lac as well, was performed against all structures in the Protein Data Bank using the program SARF (Alexandrov, 1996) to which differs from D-ala-D-ala by the substitution of an oxygen for the bridging amide. Examination of the identify any existing structural homologs to VanX. This search identified two such proteins, which were preVanX:D-ala-D-ala complex ( Figure 4B ) reveals that the bridging lactate oxygen would be positioned within 3.2 viously postulated to be similar to VanX (McCafferty et al., 1997) : D-ala-D-ala carboxypeptidase from S. albus Å and 3.4 Å of the main-chain carbonyls of Tyr-109 and Val-110, respectively. This oxygen would also be G (Dideberg et al., 1982; Joris et al., 1983 ) (DDC, PDB accession 1LBU) and the N-terminal fragment of murine positioned within 4.1 Å of the negatively charged Glu-181. While this is favorable for the positively charged Sonic hedgehog (Hall et al., 1995) (MSH, PDB accession 1VHH). The first, DDC, is a protein believed to be indipeptide amide, which is also capable of donating a hydrogen bond, it would prove unfavorable for the parvolved in digestion of the bacterial cell-wall peptidoglycan (Dideberg et al., 1982) . However, unlike VanX, which tially negatively charged lactate oxygen, which is also incapable of accepting any external hydrogen bonds at we have shown to be an amino-peptidase, it is a carboxy-peptidase (Dideberg et al., 1982) . The second, this position (the side chain of Tyr-109, which is capable of acting as a hydrogen-bond donor, is pointing away MSH, is a fragment of a eukaryotic protein involved in natal morphogenesis and the formation of embryonic from the substrate and into a grouping of aromatic residues). As is the case with the phosphonate compound, patterning centers (Hall et al., 1995) ; while its N terminus contains a recognized catalytic domain, its native subin D-ala-D-lac there is a possibility of internal hydrogen bonding between the terminal amino group and the strate has not yet been discovered (Hall et al., 1995) . The two proteins show large areas of structural similarity bridging lactate oxygen that would prevent effective hydrogen bonding of the amino group with the protein.
centered around the region of the active site and the ␤ sheet: DDC overlapped with VanX on 114 ␣ carbons The combination of loss of hydrogen bonding and the with an rms deviation of 1.98 Å , while N-terminal MSH effect of electrostatic screening would lead to the oboverlapped with VanX on 92 ␣ carbons with an rms served preclusion of D-ala-D-lac. deviation of 2.35 Å ( Figure 6A ). This structural homology extends beyond the main chain: several of the residues Primary and Tertiary Structural Homology within the catalytic sites of the proteins are conserved. Presently, there have been five VanX orthologs isolated As shown in Figure 6B , many vital catalytic residues or identified from five separate organisms. Two have within VanX have a homolog within DDP and MSH. The been isolated from enterococci (E. faecium [Wu et al., triad of residues responsible for coordinating the zinc 1995] and E. faecilis ) and in VanX (His-116/Asp-123/His-184) are mirrored in DDC one from Streptomyces toyocaensis (Marshall et al., and MSH (His-141/Asp-148/ 1998). Two have been identified on the basis of seHis-183), as is Glu-181, the side chain responsible for quence similarity from public genome data bases: one the formation of the catalytic base (His-192 in DDC and from Escherichia coli (C. Hutchins, personal communiGlu-177 in MSH). Arg-71 is also mimicked in DDC by cation) and one from Synechocysitis sp. PCC6803. SeArg-138 and in MSH by a histidine (His-135). Ser-114, which is seen interacting with the ␤-carboxylate moiety quence alignment reveals a dichotomy in the clustering Residues shaded in black at a particular position indicate a 100% identity over all sequences. Residues shaded in gray at a particular position indicate amino acid homology between three sequences. Residues that form the active site are labeled with an "A." Alignment was performed using CLUSTAL W (Thompson et al., 1994) and illustrated using the program BOXSHADE.
within a long channel along one face of the protein.
Likewise, the active site of DDC is positioned within a similar channel at the far edge of the C-terminal domain. This placement is consistent with each protein's function. While its exact role and native substrate have yet to be confirmed, it has been suggested that the proteolytic role of MSH may be to cleave either itself (through autoproteolysis) or another protein, thereby modulating a particular activity (Hall et al., 1995) . DDC is believed to cleave the D-ala-D-ala terminus of peptidoglycan chains while attached to the outer edge of the cell wall (Dideberg et al., 1982) . Both of these functions necessitate having a readily accessible active site, which would be provided by placing the active site within a channel. In VanX, however, the substrate is small and the enzyme has adapted by placing the active site within a narrow pocket to better control access. The pocket is formed with the help of a "flap" provided by residues 83-111. This flap extends over a portion of the VanX molecule that is similar to the channel seen in both DDC and MSH. It is clear that, due to the extended structural similarity, these three proteins are members of the same superfamily. The structure allows us to both confirm the conclusions is labelled. All structural alignments were done using the program of, and expand upon, the previous biochemical charac- SARF (Alexandrov, 1996) . McCafferty et al., albus G (gold) gram-negative bacteria needs to be identified and their biochemistry outlined. It is expected that the structure of VanX will aid in this endeavor, perhaps in allowing us in the D-ala-D-ala complex, is structurally conserved in both DDC (Ser-152) and MSH (Ser-139). which to construct homology models of these orthologs. The structural information, in combination with the strucis positioned to interact with the transition state as shown by the phosphonate and phosphinate analog tures of the enzyme in complex with substrate and inhibitors, can also be exploited for the rational design of complexes, has its indole ring replaced by a histidine ring in both DDC .
Conclusion
inhibitors that would be used to circumvent vancomycin resistance by inhibition of VanX. The high level of seComparison of the overall folds of the three proteins is also revealing ( Figure 6A ). The smallest protein of quence identity between VanX proteins from E. faecium, E. faecilis, and S. toyocaensis strongly suggests that an the three, the MSH fragment, presents its catalytic site water molecules were added using the "hydrate" function of inhibitor directed against the VanX protein of one spe-
QUANTA. The refinement steps were run a final time to position the cies will be effective in inhibiting the VanX proteins from water molecules. For the substrate-product soak and the transitionthe other two species. There will still be challenges in state analog soaks, an equivalent procedure was used. For subthe design of such compounds, due to the limited size strate-product soaks, a crystal was presoaked in stabilization soluof the active site.
tion containing 1 mM 1,10-phenanthroline for 1-2 hr to scavenge endogenous zinc. The crystal was then soaked in stabilizing solution containing 1 mM CuCl 2 for 2 hr. The crystal was then transferred to Experimental Procedures stabilizing solution containing 1 mM CuCl 2, 160 mM D-alanyl-D-ala, and 16 mM D-alanine. This crystal was transferred to fresh stabilizing Protein Expression and Purification solution supplemented with CuCl 2, D-alanyl-D-alanine, and D-alaThe following protocol is a modification of the protocol used by nine, every 30 min for 2 hr to maintain consistent concentrations of Walsh and colleagues (Wu et al., 1995) . E. coli W3110 containing the compounds. Diffraction data was then collected. Competitive plasmid pGW1, in which the vanX gene is under control of the IPTG-D-alanyl-D-alanine/D-alanine soaks were used because initial exinducible tac promoter, was grown at 37ЊC in LB medium containing periments using only high concentrations of D-alanyl-D-alanine reampicillin (100 g/ml) to an A 595 of 1.3-1.5 a.u. (absorbance units). vealed density for D-ala-D-ala in one molecule with the other active IPTG was then added to a final concentration of 0.8 mM, and the sites empty. It was anticipated that these sites would be able to bind cells were grown for an additional 1.5 hr. Cells were harvested by D-alanine. The reason for the dichotomy of binding is not completely centrifugation at 6000 rpm for 10 min, and the pellet was resusunderstood, but may be due to differing accessibility of each active pended in ice-cold 20 mM Tris-HCl (pH 8.0) containing 0.01% NaN 3, site within the ASU for the divalent copper. For transition-state ana-1 mM MgCl2, 1 mM PMSF, 1 mM DTT (Buffer A), and 25 U/ml log soaks, the crystals were soaked in stabilizing solution suppleBenzonase. The cells were lysed by the addition of 0.1 m zirconia mented with 1 mM ZnCl 2 and 5 mM of the transition-state analog ceramic beads to the lysate mixture (1:1 v:v) with a 1-3 min run in for 4 hr. The high-resolution apo-VanX structure was used as an a Bead Beater (Biospec), an ultrasound bead mill. The lysate was initial model that was then properly positioned within the new unit centrifuged at 25,000 g for 30 min to settle cell debris. The supernacell using rigid-body refinement, followed by the refinement protocol tant was dialyzed overnight at 4ЊC in 50 mM Tris-HCl (pH 7.6), 1 outlined above. The ligands were then built into their representative mm EDTA, and 1 mM DTT (Buffer B). The dialyzed lysate was then densities, structural waters added as above, and the refinement loaded onto a Q-Sepharose fast-flow column, preequilibrated in protocol reexecuted. Analysis by PROCHECK (Laskowski et al., Buffer A, at a rate of 4 mm/min. The column was exhaustively 1993) and 3D profiles (Luthy et al., 1992) shows that the models are washed with the Buffer A followed by a linear gradient of Buffer B consistent with refined protein structures. to Buffer B ϩ 0.5 M NaCl. The active VanX fractions from this step were pooled and concentrated and then applied to a Superose-75 column in Buffer B. VanX fractions from the Superose column run Acknowledgments were applied to a Source-Q column in Buffer A at a flow rate of 2 ml/min. The column was washed with starting buffer for several
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